Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ARTHUR KOROTKIN

Allopathic & Osteopathic Physicians Ophthalmology

NPI
1023166345
CMS profile
1075705
Location
FORT COLLINS, CO

General Payments · PY2018–2024

$2,063.85

  • Reported across 75 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$424.86

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $424.86 13

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Regeneron Healthcare Solutions, Inc. $159.43 3
Genentech USA, Inc. $85.66 1
ABBVIE INC. $59.10 3
Astellas Pharma US Inc $35.93 2
GLAUKOS CORPORATION $28.49 1
Biogen, Inc. $20.04 1
Carl Zeiss Meditec USA, Inc. $18.48 1
Sandoz Inc. $17.73 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $514.46 11
PY2019 $382.18 14
PY2020 $256.93 11
PY2021 $107.66 6
PY2022 $182.49 9
PY2023 $195.27 11
PY2024 $424.86 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $25.17 06/05/2024 Food and Beverage Undisputed 01/23/2026 1104100256 CMS
ABBVIE INC. $18.30 07/22/2024 Food and Beverage Undisputed 01/23/2026 1104100258 CMS
ABBVIE INC. $15.63 09/18/2024 Food and Beverage Undisputed 01/23/2026 1104100260 CMS
Astellas Pharma US Inc $20.39 03/20/2024 Food and Beverage Undisputed 01/23/2026 1139304264 CMS
Astellas Pharma US Inc $15.54 07/17/2024 Food and Beverage Undisputed 01/23/2026 1139298880 CMS
Biogen, Inc. $20.04 02/28/2024 Food and Beverage Undisputed 01/23/2026 1104838151 CMS
Carl Zeiss Meditec USA, Inc. $18.48 07/10/2024 Food and Beverage Undisputed 01/23/2026 1153259796 CMS
Genentech USA, Inc. $85.66 10/23/2024 Food and Beverage Undisputed 01/23/2026 1132979065 CMS
Glaukos Corporation $28.49 06/24/2024 Food and Beverage Undisputed 01/23/2026 1151985100 CMS
Regeneron Healthcare Solutions, Inc. $37.39 11/12/2024 Food and Beverage Undisputed 01/23/2026 1114091349 CMS
Regeneron Healthcare Solutions, Inc. $94.24 11/13/2024 Food and Beverage Undisputed 01/23/2026 1114091351 CMS
Regeneron Healthcare Solutions, Inc. $27.80 12/18/2024 Food and Beverage Undisputed 01/23/2026 1114091353 CMS
Sandoz Inc. $17.73 04/24/2024 Food and Beverage Undisputed 01/23/2026 1089368402 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.